Supplementary Table from Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Autor: Zhi-Ming Shao, Zhong-Hua Wang, Wen-Tao Yang, Jian-Jun Zou, Xiao-Yu Zhu, Yanhui Xu, Xizi Chen, Xiaomao Guo, Wen-Jun Chai, Xiang-Jie Sun, Ying Xu, Xiao-Yan Ma, Shen Zhao, Xin Hu, A-Yong Cao, Xiao-Yan Huang, Can-Ming Chen, Zhen Hu, Yi-Feng Hou, Jun-Jie Li, Lei Fan, Ke-Da Yu, Guang-Yu Liu, Gen-Hong Di, Jiong Wu, Song-Yang Wu, Yi-Zhou Jiang, Li Chen
Rok vydání: 2023
Popis: Supplementary Table from Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
Databáze: OpenAIRE